Benzonitrile, 3-[[3-ethyl-1,2,3,6-tetrahydro-5-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl]carbonyl]-5-methyl- manufacturers
- KM-023
-
- $92.00
-
2026-07-27
- CAS:1097628-00-6
- Purity: 99.03%
- Supply Ability: 10g
|
| | Benzonitrile, 3-[[3-ethyl-1,2,3,6-tetrahydro-5-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl]carbonyl]-5-methyl- Basic information |
| Product Name: | Benzonitrile, 3-[[3-ethyl-1,2,3,6-tetrahydro-5-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl]carbonyl]-5-methyl- | | Synonyms: | Benzonitrile, 3-[[3-ethyl-1,2,3,6-tetrahydro-5-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl]carbonyl]-5-methyl-;KM-023;Gefitinib Impurity 115;KM-023, 10 mM in DMSO;3-(3-Ethyl-5-isopropyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carbonyl)-5-methylbenzonitrile | | CAS: | 1097628-00-6 | | MF: | C18H19N3O3 | | MW: | 325.36 | | EINECS: | | | Product Categories: | | | Mol File: | 1097628-00-6.mol | ![Benzonitrile, 3-[[3-ethyl-1,2,3,6-tetrahydro-5-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl]carbonyl]-5-methyl- Structure](CAS/20200515/GIF/1097628-00-6.gif) |
| | Benzonitrile, 3-[[3-ethyl-1,2,3,6-tetrahydro-5-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl]carbonyl]-5-methyl- Chemical Properties |
| | Benzonitrile, 3-[[3-ethyl-1,2,3,6-tetrahydro-5-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl]carbonyl]-5-methyl- Usage And Synthesis |
| Uses | Ainuovirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI). Ainuovirine inhibits HIV replication by non-competitively binding to HIV reverse transcriptase and blocking the reverse transcription process of viral RNA. Ainuovirine can be used for human immunodeficiency virus (HIV) type 1 infection[1]. | | References | [1] Cha Y J, et al. Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse-transcriptase inhibitor KM-023 in healthy subjects[J]. Drug Design, Development and Therapy, 2014: 1613-1619. DOI:10.2147/DDDT.S65596 |
| | Benzonitrile, 3-[[3-ethyl-1,2,3,6-tetrahydro-5-(1-methylethyl)-2,6-dioxo-4-pyrimidinyl]carbonyl]-5-methyl- Preparation Products And Raw materials |
|